Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Apl Healthcare Limited, is an unlisted public company incorporated on 19 December, 2006. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 240.00 cr and the total paid-up capital is INR 216.00 cr.
Apl Healthcare Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 14.24% over the previous year. At the same time, it's book networth has increased by 46.81%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 97.7 | 466.6 | 2,146.0 | 3,138.9 | 3,130.1 |
Operating profit | -5.3 | 121.6 | 510.4 | 583.0 | 749.5 |
Net profit | -32.8 | 66.3 | 399.8 | 473.8 | 495.0 |
Gross margin | 39.7 | 48.9 | 44.1 | 37.0 | 42.1 |
Operating margin | -5.4 | 26.1 | 23.8 | 18.6 | 23.9 |
Net margin | -33.2 | 14.2 | 18.5 | 14.8 | 15.6 |
Networth | 82.1 | 149.0 | 867.6 | 1,273.8 | 1,738.1 |
Borrowings | 241.0 | 355.5 | 960.2 | 1,036.2 | 972.4 |
Assets | 400.2 | 740.1 | 2,516.5 | 2,864.5 | 3,262.2 |
Debt to equity | 2.9 | 2.4 | 1.1 | 0.8 | 0.6 |
Current ratio | 0.4 | 0.5 | 1.8 | 2.1 | 2.8 |
ROE | -39.9 | 44.5 | 46.1 | 37.2 | 28.5 |
Days payable | 248.0 | 220.0 | 194.0 | 93.0 | 95.0 |
WC days | -681.0 | -212.0 | 103.0 | 102.0 | 153.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 216.0 | 216.0 | 216.0 | 216.0 | 216.0 |
Reserves | -133.9 | -67.0 | 651.6 | 1,057.8 | 1,522.1 |
Borrowings + | 241.0 | 355.5 | 960.2 | 1,036.2 | 972.4 |
Long term borrowings | 6.0 | 6.0 | 913.9 | 808.3 | 785.6 |
Short term borrowings | 235.0 | 349.5 | 46.3 | 227.9 | 186.8 |
Trade payables + | 40.0 | 143.9 | 639.4 | 501.0 | 472.0 |
Days payable | 248.0 | 220.0 | 194.0 | 93.0 | 95.0 |
Other liabilities + | 77.0 | 235.6 | 688.6 | 554.5 | 551.6 |
Other non-current liabilities | 1.3 | - | 7.7 | 15.2 | 19.3 |
Other current liabilities | 35.7 | 91.7 | 41.6 | 38.3 | 60.3 |
Total liabilities | 400.2 | 740.1 | 2,516.5 | 2,864.5 | 3,262.2 |
Fixed Assets + | 266.5 | 407.8 | 1,139.0 | 1,092.5 | 1,088.3 |
Tangible assets | 257.1 | 358.4 | 1,055.5 | 1,061.4 | 988.0 |
CWIP | 9.4 | 49.3 | 83.5 | 31.1 | 100.3 |
Intangible assets | - | - | - | - | - |
LT loans and advances | - | 0.2 | 0.6 | 0.1 | - |
Other non-current assets | 5.1 | 18.5 | 41.5 | 124.2 | 139.4 |
Current assets + | 128.5 | 313.6 | 1,335.3 | 1,647.7 | 2,034.5 |
Inventories | 62.0 | 88.8 | 638.8 | 614.4 | 921.9 |
Trade receivables | 61.6 | 210.6 | 679.4 | 984.2 | 1,062.5 |
Cash and cash equivalents | 2.3 | 5.0 | 0.9 | 9.6 | 11.9 |
ST loans and advances | 0.1 | 0.2 | 0.9 | 1.0 | 0.6 |
Other current assets | 2.5 | 9.0 | 15.3 | 38.5 | 37.6 |
Total assets | 400.2 | 740.1 | 2,516.5 | 2,864.5 | 3,262.2 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 97.7 | 466.6 | 2,146.0 | 3,138.9 | 3,130.1 |
Sales growth % | 2062.72 | 377.76 | 359.9 | 46.27 | -0.28 |
Expenses + | 131.5 | 400.8 | 1,752.9 | 2,724.0 | 2,552.3 |
Cost of goods | 58.9 | 238.6 | 1,200.4 | 1,976.9 | 1,811.6 |
Employee cost | 21.7 | 45.8 | 146.1 | 166.0 | 198.8 |
Other costs | 22.3 | 60.7 | 289.2 | 412.9 | 370.2 |
Operating profit + | -5.3 | 121.6 | 510.4 | 583.0 | 749.5 |
Operating margin % | -5.4 | 26.1 | 23.8 | 18.6 | 23.9 |
Other income | 1.1 | 0.5 | 19.8 | 60.0 | 37.3 |
Interest | 13.1 | 31.3 | 29.7 | 71.1 | 71.0 |
Depreciation | 15.5 | 24.4 | 87.6 | 97.0 | 100.7 |
Exceptional items | - | - | - | - | - |
Profit before tax | -32.8 | 66.3 | 412.8 | 474.8 | 615.0 |
Tax | - | - | 13.0 | 1.1 | 120.0 |
Profit - disc. ops | - | - | - | - | - |
Net profit | -32.8 | 66.3 | 399.8 | 473.8 | 495.0 |
Net margin % | -33.2 | 14.2 | 18.5 | 14.8 | 15.6 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 2.9 | 2.4 | 1.1 | 0.8 | 0.6 |
Net Debt/Equity | 2.9 | 2.4 | 1.1 | 0.8 | 0.6 |
Total Debt/Assets | 0.6 | 0.5 | 0.4 | 0.4 | 0.3 |
Total Assets/Equity | 4.9 | 5.0 | 2.9 | 2.2 | 1.9 |
Liquidity + | |||||
Current Ratio | 0.4 | 0.5 | 1.8 | 2.1 | 2.8 |
Quick Ratio | 0.2 | 0.4 | 1.0 | 1.4 | 1.6 |
Interest Coverage | -0.4 | 3.9 | 17.2 | 8.2 | 10.6 |
Performance | |||||
Gross Margin | 39.7 | 48.9 | 44.1 | 37.0 | 42.1 |
Operating Margin | -5.4 | 26.1 | 23.8 | 18.6 | 23.9 |
Net Margin | -33.2 | 14.2 | 18.5 | 14.8 | 15.6 |
Return + | |||||
Return on Equity | -39.9 | 44.5 | 46.1 | 37.2 | 28.5 |
Pre-tax ROCE | -24.6 | 71.2 | 24.2 | 24.6 | 27.0 |
Return on Assets | -8.2 | 8.9 | 15.9 | 16.5 | 15.2 |
Pre-tax ROIC | -6.5 | 19.4 | 23.1 | 21.1 | 24.0 |
Efficiency + | |||||
Days Payable | 248.0 | 220.0 | 194.0 | 93.0 | 95.0 |
Days Inventory | 384.0 | 136.0 | 194.0 | 113.0 | 186.0 |
Days Receivable | 230.0 | 165.0 | 116.0 | 114.0 | 124.0 |
Fixed Asset Turnover | 0.4 | 1.1 | 1.9 | 2.9 | 2.9 |
Total Asset Turnover | 0.2 | 0.6 | 0.8 | 1.1 | 1.0 |
Working Capital | |||||
Cash Conversion Cycle | 366.0 | 81.0 | 116.0 | 134.0 | 215.0 |
Working Capital Days | -681.0 | -212.0 | 103.0 | 102.0 | 153.0 |
As per information available, the company has no registered charges.
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Nityananda Reddy Kambam
Shareholder
|
01284195 | 18 years |
Director | Sivakumaran Meenakshisunderam
Shareholder
|
01284320 | 18 years |
CFO | Suryanarayana Murthy Mula | <HIDDEN> | 4 years |
Whole-time Director | Venkatanarayana Reddy Jayampu | 08427188 | 6 years |
Director | Mylandlahalli Rammohan Ashwini | 10568862 | 1 years |
CS | Salgunan Komatheruvan Chettivalappil | <HIDDEN> | 3 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
HYACINTHS PHARMA PRIVATE LIMITED |
Amalgamated
|
32.5 Cr | 1 | Telangana |
AUROBINDO PHARMA LTD |
Active
|
58.1 Cr | 1 | Telangana |
TRIDENT LIFE SCIENCES LIMITED |
Amalgamated
|
1.6 L | 2 | Telangana |
RAIDURGAM DEVELOPERS LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
APL RESEARCH CENTRE LIMITED |
Amalgamated
|
12.3 Cr | 2 | Telangana |
SENOR ORGANICS PVT LTD |
Amalgamated
|
1.5 Cr | 1 | Telangana |
AUROZYMES LIMITED |
Amalgamated
|
5.0 L | 2 | Telangana |
SILICON LIFE SCIENCES PRIVATE LIMITED |
Amalgamated
|
110.0 Cr | 2 | Telangana |
AUROBINDO ANTIBIOTICS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Andhra Pradesh |
QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
AUROBINDO PHARMA FOUNDATION |
Active
|
1.0 L | 2 | Telangana |
APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 2 | Telangana |
PATTANCHERU ENVIRO-TECH LIMITED |
Active
|
2.6 Cr | 1 | Telangana |
LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 1 | Telangana |
AUROACTIVE PHARMA PRIVATE LIMITED |
Active
|
100.0 Cr | 2 | Telangana |
AURO PEPTIDES LIMITED |
Active
|
265.9 Cr | 1 | Telangana |
TERGENE BIOTECH LIMITED |
Active
|
45.0 Cr | 1 | Telangana |
EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 1 | Telangana |
CURATEQ BIOLOGICS PRIVATE LIMITED |
Active
|
100.0 Cr | 2 | Telangana |
GLS PHARMA LIMITED |
Active
|
1.2 Cr | 1 | Delhi |
OHAPRA LLP |
Active
|
50,000.0 | 1 | Telangana |
AURO VACCINES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 1 | Telangana |
The incorporation date of APL HEALTHCARE LIMITED is 19 December, 2006
The authorized share capital of APL HEALTHCARE LIMITED is INR ₹ 240.0 Cr.
The paid-up capital of APL HEALTHCARE LIMITED is INR ₹ 216.0 Cr.
The registered address of APL HEALTHCARE LIMITED is PLOT NO. 2 MAITHRI VIHAR, AMEERPET NA HYDERABAD Telangana - 500038
The CIN number of APL HEALTHCARE LIMITED is U24239TG2006PLC052053.